<DOC>
	<DOCNO>NCT01864174</DOCNO>
	<brief_summary>The purpose study determine Metformin XR monotherapy subject type 2 diabetes non-inferior Metformin IR monotherapy</brief_summary>
	<brief_title>Phase 4 : Investigational Study Evaluate Metformin XR Monotherapy Versus Metformin IR Monotherapy Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>For information regard BMS clinical trial participation , please visit www.BMSStudyConnect.com Men woman , age ≥18 year old time enrollment Treatment naive subject type 2 diabetes mellitus inadequate glycemic ( HbA1c ≥7.0 % ≤9.2 % obtain screening visit ) control diet exercise alone Women must negative serum urine test within 24 hour prior start investigational product History ketoacidosis , lactic acidosis hyperosmolar nonketonic coma Symptoms poorly control diabetes , include limited mark polyuria polydipsia &gt; 10 % weight loss last 3 month Serum creatinine ≥1.50 mg/dL ( 133 μmol/L ) male subject ; serum creatinine ≥1.40 mg/dL ( 124 μmol/L female subject )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
</DOC>